Background. Using genotyping techniques that have differentiated Mycobacterium bovis from Mycobacterium tuberculosis since 2005, we review the epidemiology of human tuberculosis caused by M. bovis in the United States and validate previous findings nationally.
Mycobacterium bovis is one of several mycobacteria of the Mycobacterium tuberculosis complex that are closely related and pathogenic [1] . Although M. bovis has a wide range of wild and domestic animal hosts [2] , consumption of unpasteurized (raw) bovine milk and dairy products made from it (eg, queso fresco) is considered to be the primary mode of disease transmission in humans [3] [4] [5] , although some smaller studies using molecular tools to identify and link patients with M. bovis tuberculosis disease have provided evidence of person-to-person transmission through the inhalation of infected droplet nuclei (ie, the primary mode of transmission for M. tuberculosis), particularly among immunocompromised patients [6] [7] [8] . Subsequent investigations have further expanded these findings by identifying personto-person transmission in immunocompetent patients as well [9] [10] [11] . Because M. bovis and M. tuberculosis disease are clinically indistinguishable, genotyping can be used to help differentiate between the 2 causative agents [12] . Determining this distinction is epidemiologically valuable for tuberculosis control as disease caused by M. bovis may require distinct interventions to interrupt transmission.
In 2004, the US Centers for Disease Control and Prevention (CDC) initiated the National Tuberculosis Genotyping Service (NTGS) [13] . To achieve universal genotyping coverage, NTGS aims to perform genotyping on an isolate for every cultureconfirmed tuberculosis case in the United States [14] . Results from 2 standardized genotyping methods, spacer oligonucleotide typing (spoligotyping) and mycobacterial interspersed repetitive unit-variable number tandem repeat typing (MIRU-VNTR), are combined to determine the genotype [15, 16] . Not all US jurisdictions participated in NTGS until 2006 [13, 14] , and national genotyping coverage improved from 51.2% in 2004 to 94.6% in 2013 [14, 17] .
A previous analysis of US tuberculosis surveillance data from 1995 to 2005 found that M. bovis disease was associated with being born outside the United States, identifying as Hispanic, being <15 years of age, reporting human immunodeficiency virus (HIV) infection, and having extrapulmonary tuberculosis [18] , but the national representativeness of these findings was limited by low participation rates in NTGS [19] . Other subnational analyses describing the epidemiology of M. bovis have been published using data from California's tuberculosis surveillance system, which reports roughly half of all M. bovis cases nationally [20, 21] .One analysis of California-specific data identified diabetes and immunosuppressive conditions (excluding HIV coinfection) as factors associated with M. bovis disease [20] . We reviewed the epidemiology of human tuberculosis caused by M. bovis in the United States and validated previous findings using an expanded data set with more complete genotype surveillance data.
METHODS
NTGS data linked with tuberculosis patient data from the National Tuberculosis Surveillance System (NTSS) [14] reported to the CDC by state and local partners were analyzed. All cultureconfirmed tuberculosis cases reported and counted by the 50 US states and the District of Columbia during 2006-2013 were eligible for analysis. An additional variable identifying country of birth for the parents or guardians of pediatric tuberculosis patients was added to the NTSS in 2009, expanding analysis potential for country of parental origin [22] .
Spoligotyping and MIRU-VNTR results were used to define cases as caused by M. tuberculosis, M. bovis, or M. bovis bacille Calmette-Guerin (BCG) strain [16] . The genotype-based definition for M. bovis requires either (1) the absence of spoligotyping spacers 3, 9, 16, and 39-43; the presence of at least 1 of the spacers 29-32; and the presence of at least 1 of the spacers 33-36; (2) the absence of spacers 3, 9, 16, and 39-43 and ≥2 copies of the repeated sequence at MIRU locus 24 (ie, loci 2687); or (3) determination based on microbiologic expertise. Patients with M. bovis BCG strain isolates were defined as spoligotype 676773777777600 with x, y, or z in the second MIRU position [18, 23] . All M. bovis BCG cases were assumed to be iatrogenic [24] and were excluded from analysis. Patients with M. tuberculosis complex isolates that were classified as other than M. tuberculosis or M. bovis (ie, M. africanum, M. canetti, M. caprae, M. microti, M. mungi, M. pinipedii, M. suricattae) were also excluded from analysis.
We assessed trends during the 8-year study period by analyzing the annual proportions of M. bovis-attributed disease stratified by country of birth, race/ethnicity, age, sex, residence along the USMexico border, mortality, and disease site (defined as pulmonary, extrapulmonary, or both). Residence along the US-Mexico border was defined using 3 mutually exclusive categories: nonborder states (ie, any state except Arizona, California, New Mexico, and Texas), border counties within a border state (ie, any county directly adjacent to the US-Mexico border), and nonborder counties within a border state. Region of birth was assigned according to World Health Organization designations [25] . Outcome data on treatment completion and death during treatment were available only for 2006-2011 per the NTSS follow-up reporting schedules [26] .
We calculated cumulative incidence rates using county-and national-level case counts and corresponding population estimates from the US census at the start of the study period [27] . We compared demographic and clinical characteristics between M. bovis and M. tuberculosis cases. We used Pearson χ 2 and Fisher exact tests to detect significant differences in bivariate analyses of categorical data; for continuous variables, we used the Wilcoxon rank-sum test. For all statistical tests, we considered an α level <.05 to be significant. Prevalence ratios (PRs) and corresponding 95% confidence intervals (CIs) were used to measure associations between patients' demographic and clinical characteristics and M. bovis disease. We used log-binomial regression to identify characteristics independently associated with M. bovis disease based on adjusted prevalence ratios (aPRs) and corresponding 95% CIs. Multivariate analysis stratified cases by place of birth (ie, US-born vs foreign-born) to further characterize the epidemiology of M. bovis disease. The models were reduced using backward elimination, maintaining variables with P values <.05. Model fit was assessed using the likelihood ratio test. Figure 1A ).
RESULTS

During
Patients with M. bovis disease were younger than patients with M. tuberculosis disease (median age, 38 vs 46 years, respectively; Table 1 ). Female patients with M. bovis had a higher Figure 1B) .
Geographically, the cumulative incidence rate of M. bovis during 2006-2013 was higher in counties along the US-Mexico border than the national average of cumulative incidence (0.29 per 100 000 persons [95% CI, .26-.29]; Figure 2 ). Eleven counties had an incidence >5.0 per 100 000 persons. Almost half (44%) of patients with M. bovis disease were residents of a nonborder county in a state along the US-Mexico border at the time of diagnosis; an additional 21.5% of patients were residents of a county directly adjacent to the US-Mexico border.
Of the 770 M. bovis tuberculosis patients with pyrazinamide drug susceptibility test results, 721 (93.6%) were resistant to pyrazinamide. Of the 851 M. bovis isolates with drug susceptibility test results to isoniazid and rifampin, 4 (0.5%) demonstrated resistance to both drugs and were considered multidrug resistant. During
After stratifying M. bovis patients by place of birth, the majority of US-born (88.6%) and foreign-born (95.3%) patients with M. bovis tuberculosis disease were Hispanic (Table 2) . US-born M. bovis tuberculosis disease occurred more often among residents living in counties directly adjacent to the US-Mexico border at the time of diagnosis (33%) compared with foreign-born patients with M. bovis disease (18.4%). US-born patients with M. bovis disease were more often diagnosed with exclusively extrapulmonary disease compared with foreign-born patients (54.6% vs 40.8%, respectively). More than half of US-born patients were female (58.5%). More than one-third (36.9%) were children <15 years of age; by comparison, 1.9% of foreign-born patients were children. Twenty-three US-born children with M. bovis disease and available data had ≥1 parent who was born in Mexico. Of the 23 children with Mexican-born parents identified, 21 (91.3%) were diagnosed with exclusively extrapulmonary tuberculosis disease.
In multivariate analyses comparing M. bovis to M. tuberculosis among US-born patients ( (aPR, 2.7 [95% CI, 1.9-3.7]) each had a higher prevalence of M. bovis disease than the specified referent categories. Among foreign-born patients, females (aPR, 1.6 [95% CI, 1. 
DISCUSSION
In this population-level study of linked epidemiologic and molecular surveillance data, we found that annual proportions of tuberculosis disease attributable to M. bovis have remained relatively stable from 2006 through 2013, accounting for 1.3%-1.6% of all reported tuberculosis cases in the United States. This is comparable to a similar finding that the annual proportion of M. bovis tuberculosis disease ranged from 1.6% to 2.0% nationally during 1999-2009 [28] . Supporting prior studies in the United States, we observed a disproportionate amount of M. bovis disease among Hispanics, foreign-born patients, children (<15 years of age), and patients with extrapulmonary disease [18, 20, 29] . We also found an increased proportion of M. bovis disease among females, corroborating a previous study from the Netherlands [30] .
In our analysis, female sex was associated with M. bovis tuberculosis disease; this association was particularly strong among US-born females. Although other studies have not reported an association between female sex and tuberculosis due to M. bovis, international research suggests an association between sex and site of disease (ie, pulmonary vs extrapulmonary) [30] . In a study of patients with M. bovis tuberculosis in the Netherlands, Dutch and foreign-born women were more likely than men to experience extrapulmonary tuberculosis disease infection in a lymph node (typically cervical). We also found that females have a higher proportion of extrapulmonary M. bovis tuberculosis disease, which compares to other studies showing an association between female sex and extrapulmonary tuberculosis due to M. tuberculosis [31, 32] . In an effort to examine potential sex differences in consumption of unpasteurized dairy products, the primary route of extrapulmonary M. bovis infection, we requested population-based survey data from FoodNet on food exposures in the United States. Data from the most recent survey cycle (2006-2007) do not suggest differences by sex in consumption of homemade or store-bought Mexican-style cheese, such as queso fresco, or in consumption of any cheese made from unpasteurized milk (CDC, unpublished data) [33] . Additional research is needed to understand the apparent associations between female sex, extrapulmonary disease, and M. bovis tuberculosis disease. Contact investigations can identify patients with active tuberculosis disease and latent tuberculosis who are candidates for treatment, thus averting additional cases of tuberculosis disease [34] . However, tuberculosis practitioners and clinicians may not consider conducting contract tracing activities for patients with M. bovis disease because M. bovis is associated with extrapulmonary disease (ie, noninfectious because droplet nuclei are not produced for airborne transmission). We found that more than half (56.4%) of M. bovis patients had pulmonary involvement. Among exclusively pulmonary M. bovis patients, the proportions of patients who were sputum smear positive (69.2%) or had cavitary disease at diagnosis (40.7%) were similar to those of M. tuberculosis patients (61.7% and 41.4%, respectively). These data suggest that airborne transmission is responsible for a substantial proportion of M. bovis cases. Notably, a report of contact investigations for 2 patients with pulmonary M. bovis tuberculosis disease found that 45 of 181 (24.9%) contacts had latent tuberculosis, including 6 contacts with latent tuberculosis identified at 2-month follow-up [11] . Clinicians and public health officials should thoroughly evaluate the disease presentation of each tuberculosis patient to apply appropriate control practices in healthcare and community settings, including contact tracing.
As previously reported [20] , we found that a significant number of patients with M. bovis in the United States were born in Mexico, or were first-generation descendants of someone born in Mexico. We also found that younger age was associated with M. bovis disease, even after controlling for site of disease. Furthermore, most (83.3%) of the 36 children diagnosed with M. bovis during 2009-2013 had exclusive extrapulmonary tuberculosis. Thus, the substantially increased prevalence of extrapulmonary disease, combined with the fact that all the USborn children with M. bovis tuberculosis disease had at least 1 Mexican parent, suggests that Mexican-born parents are sharing their cultural practices with their US-born children and serving unpasteurized dairy products, thereby providing a foodborne route for transmission [6, 20, [35] [36] [37] . However, due to limited availability of pertinent epidemiologic data, we were unable to evaluate individual-level risk factors (eg, foodborne exposures and recent travel) for this analysis. Despite this limitation, prior research has demonstrated that legal restrictions on the sale of unpasteurized milk products reduce the risk associated with dairy-related disease outbreaks [38] . Currently, US Customs and Border Protection allows importation of limited quantities of unpasteurized dairy products for personal consumption. Additional regulatory and epidemiologic investigations into the public health burden of importation of these products into the United States from Mexico and Latin America are warranted. Previous research has documented increased rates of tuberculosis disease along the US-Mexico border, particularly affecting Hispanics and foreign-born individuals [35, 39, 40] . We found that patients with M. bovis tuberculosis residing along the US-Mexico border, and particularly in California, had a higher incidence of M. bovis compared with the US national average. This may reflect the proximity and relative ease of movement between the United States and Mexico at overland border crossings compared with air transportation from Latin America into other regions of the country. This ease of movement for persons living on either side of the US-Mexico border may also allow for a steady supply of unpasteurized dairy products.
There are limitations to the generalizability of these findings. Analysis was restricted to culture-confirmed cases to allow M. tuberculosis complex strain differentiation using genotyping. Another limitation is incomplete genotyping coverage, particularly early in the study period when NTGS was not being implemented nationally [14] . Overall, 84.5% of all cultured isolates were genotyped, which allowed for differentiation between M. bovis and M. tuberculosis as well as exclusion of M. bovis BCG strain cases. Additionally, specimens for culture and genotyping are less likely to be collected from patients with extrapulmonary tuberculosis disease; only 16.0% of exclusively extrapulmonary patients were culture positive compared with 73.7% of exclusively pulmonary patients (CDC, unpublished NTGS data). This disparity limited the inclusion of additional extrapulmonary cases in our analysis. The collection of sputum for cultures is also age-dependent; in particular, children tend to be unable to produce the sputum samples required for culture confirmation and subsequent genotyping. Although children appear to have high rates of M. bovis tuberculosis, we probably have underestimated the pediatric burden of M. bovis.
Surveillance data on HIV status is another limitation in our analyses. Historically, there has been variation among states in the reporting of HIV testing results to the NTSS. California, which reports roughly half of all M. bovis cases nationally, began reporting HIV test results to the CDC in 2011. This limited our ability to analyze the association between M. bovis and HIV.
CONCLUSIONS
Our findings can inform specific interventions aimed at eliminating tuberculosis disease due to M. bovis in border regions of the United States, which disproportionately affects females, children, foreign-born persons, and Hispanics. Education initiatives aimed at teaching women, especially mothers and caregivers, about the risks associated with consuming unpasteurized milk and dairy products are needed. When M. bovis cases are detected, clinicians and public health officials should ensure that supplemental tuberculosis surveillance activities are conducted to identify additional risk factors for foodborne transmission. Additionally, interagency and cross-border collaborations can enhance and optimize the effectiveness of current importation laws regarding unpasteurized milk products entering the United States. Finally, while M. bovis is predominately characterized by an extrapulmonary clinical presentation, our finding that one-third of all cases in the United States present with exclusively pulmonary disease demonstrates the need for more research on airborne transmission of M. bovis, especially regarding its relative infectiousness compared with M. tuberculosis. 
